$ANCN Announces Shareholder Approval of the Merger with Chemomab

Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices 45.5M Private Financing

Anchiano shareholders approve all resolutions at shareholder meeting

The merged company is expected to receive approximate gross proceeds from the private financing of $45.5 million, which will be used to advance the Chemomab pipeline.

finance.yahoo.com/news/anchiano-announces-shareholder-approval-merger-215400351.html